NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a <i>Drosophila</i> tauopathy model.
Overview
- Zayed Centre for Rare Disease, UCL Great Ormond Street Institute of Child Health, University College London, London, UK
- Talisman Therapeutics, Babraham Research Campus, Cambridge CB22 3AT, UK
- The Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK
- Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3DY, UK
- Department of Cell Biology, NYU Grossman School of Medicine, New York, NY 10016, USA
- Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
- Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK
Abstract
Mutations in the gene encoding the microtubule-associated protein tau (MAPT) that are causal for frontotemporal dementia result in nuclear envelope deformation and disrupted nucleocytoplasmic transport when expressed in human neurons. A small-molecule inhibitor of the acetyltransferase NAT10 has been shown to correct similar nuclear membrane defects in Hutchinson-Gilford progeria syndrome, primarily by modulating microtubule dynamics. We report here that NAT10 inhibition and loss of function correct nuclear membrane abnormalities in human MAPT-mutant neurons. Similarly, NAT10 inhibition and haploinsufficiency correct neuronal nuclear shape defects and extend lifespan in vivo in a Drosophila model of tauopathy. NAT10 inhibition changes microtubule dynamics and corrects aberrant nucleocytoplasmic transport, and NAT10 directly interacts with regulators of microtubule dynamics in human MAPT-mutant neurons. We conclude that NAT10 mediates neuronal pathologies in tauopathies and is a potential therapeutic target in these diseases.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Data and code availability
• Data reported in this paper will be shared by the lead contact upon request. • The study in this article does not report original code. • Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Authors: added Frederick J. Livesey (0000-0001-6128-3372); removed Frederick J. Livesey
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 7 keywords, 13 funders, 41 references, 27 RRIDs.
Cite
This paper
Paonessa, F., Bizzini, B. D., Campbell, T., Coode, E., Lam, J., Solanki, R., Butler, R., Smith, J., Davidson, C. M., Larrieu, D., Brand, A. H., & Livesey, F. J. (2026). NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a &
BibTeX
@article{paonessa2026nat
author = {Paonessa, Francesco and Bizzini, Bernardo Delarue and Campbell, Tom and Coode, Emily and Lam, Jonathan and Solanki, Ravi and Butler, Richard and Smith, James and Davidson, Catherine M. and Larrieu, Delphine and Brand, Andrea H. and Livesey, Frederick J.},
title = {{NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a \&
journal = {iScience},
year = {2026},
month = jul,
volume = {29},
number = {8},
pages = {116861},
publisher = {Elsevier},
issn = {2589-0042},
doi = {10.1016/
url = {https://
pmid = {42540688},
pmcid = {PMC13426208}
}
RIS
TY - JOUR
AU - Paonessa, Francesco
AU - Bizzini, Bernardo Delarue
AU - Campbell, Tom
AU - Coode, Emily
AU - Lam, Jonathan
AU - Solanki, Ravi
AU - Butler, Richard
AU - Smith, James
AU - Davidson, Catherine M.
AU - Larrieu, Delphine
AU - Brand, Andrea H.
AU - Livesey, Frederick J.
TI - NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a &
T2 - iScience
J2 - iScience
PY - 2026
DA - 2026/
VL - 29
IS - 8
SP - 116861
SN - 2589-0042
PB - Elsevier
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a &
"container-title": "iScience",
"author": [
{
"family": "Paonessa",
"given": "Francesco"
},
{
"family": "Bizzini",
"given": "Bernardo Delarue"
},
{
"family": "Campbell",
"given": "Tom"
},
{
"family": "Coode",
"given": "Emily"
},
{
"family": "Lam",
"given": "Jonathan"
},
{
"family": "Solanki",
"given": "Ravi"
},
{
"family": "Butler",
"given": "Richard"
},
{
"family": "Smith",
"given": "James"
},
{
"family": "Davidson",
"given": "Catherine M."
},
{
"family": "Larrieu",
"given": "Delphine"
},
{
"family": "Brand",
"given": "Andrea H."
},
{
"family": "Livesey",
"given": "Frederick J."
}
],
"container-title-short":
"volume": "29",
"issue": "8",
"page": "116861",
"DOI": "10.1016/
"PMID": "42540688",
"PMCID": "PMC13426208",
"ISSN": "2589-0042",
"publisher": "Elsevier",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
22
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s44318-025-00514-0
- Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2.Journal: The EMBO journalIn common: Alzheimer's / dementia, cellular / molecular, 4 references, 2 authors
- [2] doi:10.1007/s00401-026-03018-1
- Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.Journal: Acta neuropathologicaIn common: Alzheimer's / dementia, cellular / molecular, 5 references
- [3] doi:10.1101/gr.278576.123 [code]
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a &
lt;i& gt;Drosophila& lt;/ i& gt; knock-in tauopathy model. Journal: Genome researchIn common: drosophila, Alzheimer's / dementia, cellular / molecular, 4 references - [4] doi:10.1080/19491034.2026.2697135
- Elevation of the mechanically-sensitive e protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons.Journal: Nucleus (Austin, Tex.)In common: Alzheimer's / dementia, cellular / molecular, 4 references
- [5] doi:10.1242/dmm.052492 [code]
- Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery.Journal: Disease models & mechanismsIn common: drosophila, Alzheimer's / dementia, 3 references
- [6] doi:10.1126/sciadv.adi5548
- Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import.Journal: Science advancesIn common: cellular / molecular, 3 references
- [7] doi:10.1111/acel.70091
- Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration.Journal: Aging cellIn common: cellular / molecular, 3 references
- [8] doi:10.1038/s44318-024-00156-8
- Physiological regulation of neuronal Wnt activity is essential for TDP-43 localization and function.Journal: The EMBO journalIn common: cellular / molecular, 3 references
- [9] doi:10.1038/s41380-026-03479-6
- Systems genetic dissection of brain gene expression reveals excitotoxic mechanisms of Alzheimer's disease.Journal: Molecular psychiatryIn common: drosophila, Alzheimer's / dementia, cellular / molecular, 2 references
- [10] doi:10.1186/s12864-025-12111-w [code]
- Long-read sequencing-based analyses of the adult Drosophila brain transcriptome in physiological and pathological settings.Journal: BMC genomicsIn common: drosophila, Alzheimer's / dementia, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
